|
2021
|
G/S
|
Oral transmucosal drug delivery tablets for the delivery of pharmaceutical preparations. Manufact... |
|
2019
|
Invention
|
Alcohol-resistant formulations.
This disclosure relates to extended release oral dosage forms co... |
|
2018
|
Invention
|
Abuse resistant drug formulation.
A pharmaceutical composition may include a coated particulate ... |
|
2017
|
Invention
|
Abuse-resistant and abuse-deterrent dosage forms. Disclosed herein are dosage forms demonstrating... |
|
|
Invention
|
Abuse-resistant formulations.
This disclosure relates to a sustained-release oral dosage form su... |
|
|
Invention
|
Immediate release dosage forms with abuse deterrence and alcohol resistance. The disclosure is di... |
|
|
Invention
|
Treatment of pain using hydrocodone formulations. Extended release, abuse deterrent dosage forms ... |
|
2016
|
Invention
|
Immediate release dosage forms that deter abuse by oral ingestion of multiple dosage units.
Desc... |
|
2015
|
Invention
|
Immediate release abuse-deterrent granulated dosage forms. Described are immediate release oral d... |
|
|
Invention
|
Abuse resistant drug formulation. A pharmaceutical composition may include a coated particulate w... |
|
|
G/S
|
Manufacture of pharmaceutical tablets and capsules, vitamins, food supplements and animal veterin... |
|
2014
|
Invention
|
Taste masking system for non-plasticizing drugs.
The present invention relates to taste masking ... |
|
|
Invention
|
Abuse-deterrent dosage forms.
Described are oral dosage forms that contain abuse-deterrent featu... |
|
|
Invention
|
Immediate release abuse-deterrent granulated dosage forms. Described are oral dosage forms that c... |
|
|
Invention
|
Abuse-deterrent dosage forms. Described are oral dosage forms that contain abuse-deterrent featur... |
|
|
Invention
|
Immediate release abuse-deterrent granulated dosage forms.
Described are oral dosage forms that ... |
|
|
Invention
|
Abuse-resistant formulations. The disclosure relates to a sustained-release oral dosage form for ... |
|
2012
|
Invention
|
Abuse resistant drug formulation. A pharmaceutical composition may include a granulate which may ... |
|
|
Invention
|
Abuse-resistant formulations.
This disclosure relates to a sustained-release oral dosage form fo... |
|
|
G/S
|
Development of technology in the field of pharmaceutical tablets |
|
2011
|
Invention
|
Alcohol-resistant metoprolol-containing extended-release oral dosage forms. This disclosure relat... |
|
|
Invention
|
Alcohol-resistant formulations.
This disclosure relates to an extended release oral dosage form ... |
|
|
Invention
|
Alcohol-resistant extended release dosage forms comprising venlafaxine.
This disclosure relates ... |
|
|
Invention
|
Alcohol-resistant formulations. This disclosure relates to an extended release oral dosage form c... |
|
|
Invention
|
Alcohol-resistant extended release dosage forms comprising venlafaxine. This disclosure relates t... |
|
|
Invention
|
Alcoholres i stant metoprolol - containing extended - release oral dosage forms. This disclosure ... |
|
|
Invention
|
Abuse resistant drug formulation.
A pharmaceutical composition may include a granulate which may... |
|
|
Invention
|
Abuse-resistant formulations. This disclosure relates to a sustained-release oral dosage form sui... |
|
|
Invention
|
Dosage forms for weakly ionizable compounds.
This disclosure relates to dosage forms (e.g., soli... |
|
|
Invention
|
Oral transmucosal nicotine dosage form.
The invention described herein relates to an oral transm... |
|
2010
|
Invention
|
Abuse-resistant formulations. This disclosure relates to a sustained-release oral dosage form for... |
|
2009
|
Invention
|
Oral transmucosal nicotine dosage form. Described here in are oral transmucosal solid dosage form... |
|
|
Invention
|
Dosage forms for weakly ionizable compounds. This disclosure relates to dosage forms (e.g., solid... |
|
|
G/S
|
Pharmaceutical preparation for the treatment of pain |
|
2008
|
Invention
|
Oral transmucosal nicotine dosage form.
Described herein are oral transmucosal solid dosage form... |
|
2007
|
Invention
|
Oral transmucosal nicotine dosage form. The invention described herein relates to an oral transmu... |
|
|
Invention
|
Stabilization of lorazepam. This invention relates to orally disintegrable, lorazepam-containing ... |
|
|
Invention
|
Stabilization of lorazepam.
This invention relates to orally disintegrable, lorazepam-containing... |
|
|
Invention
|
High dose orally dissolvable/disintegrable lyophilized dosage form. The present invention provide... |
|
|
Invention
|
Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles. The pre... |
|
|
Invention
|
Prednisolone salt formulations. The present invention relates to tablets containing prednisolone ... |
|
|
G/S
|
[ printed informational, promotional, and educational materials, namely, pamphlets, sheets, broch... |
|
2005
|
G/S
|
Oral transmucosal drug delivery tablets for the delivery of pharmaceutical preparations |
|
1996
|
G/S
|
Chemical substances for carrying pharmaceutical preparations and substances, vitamins and dietary... |
